Home/Filings/4/0001209191-21-035931
4//SEC Filing

Queva Christophe 4

Accession 0001209191-21-035931

CIK 0001671818other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:31 PM ET

Size

7.1 KB

Accession

0001209191-21-035931

Insider Transaction Report

Form 4
Period: 2021-05-24
Queva Christophe
CSO and SVP, Research
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-2435,56117,781 total
    Exercise: $1.81Exp: 2028-11-13Common Stock (35,561 underlying)
  • Exercise/Conversion

    Common Stock

    2021-05-24$1.81/sh+35,561$64,36571,181 total
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option vested on September 9, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Oncorus, Inc.

CIK 0001671818

Entity typeother

Related Parties

1
  • filerCIK 0001826523

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:31 PM ET
Size
7.1 KB